Whalen, W., Berger, K., Kim, J. S., Simmons, W., Ma, S.-F., Kaner, R. J., … Noth, I. (2024). TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 210(4), 508–511. https://doi.org/10.1164/rccm.202312-2224LE

Whalen, William, Kristin Berger, John S. Kim, Will Simmons, Shwu-Fan Ma, Robert J. Kaner, Fernando J. Martinez, et al. “TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.” Am J Respir Crit Care Med 210, no. 4 (August 15, 2024): 508–11. https://doi.org/10.1164/rccm.202312-2224LE.

Whalen W, Berger K, Kim JS, Simmons W, Ma S-F, Kaner RJ, et al. TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15;210(4):508–11.

Whalen, William, et al. “TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.” Am J Respir Crit Care Med, vol. 210, no. 4, Aug. 2024, pp. 508–11. Pubmed, doi:10.1164/rccm.202312-2224LE.

Whalen W, Berger K, Kim JS, Simmons W, Ma S-F, Kaner RJ, Martinez FJ, Anstrom KJ, Parfrey H, Maher TM, Hammond M, Clark AB, Thickett D, Jenkins RG, Wilson AM, Noth I. TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15;210(4):508–511.